128 related articles for article (PubMed ID: 38242322)
1. Myosin 9 and N-glycans jointly regulate human papillomavirus entry.
Zhang Y; Liu W; He F; Liu YJ; Jiang H; Hao C; Wang W
J Biol Chem; 2024 Feb; 300(2):105660. PubMed ID: 38242322
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.
Fons NR; Kines RC; Thompson CD; Day PM; Lowy DR; Schiller JT
J Virol; 2022 Apr; 96(7):e0185721. PubMed ID: 35285688
[TBL] [Abstract][Full Text] [Related]
3. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.
Surviladze Z; Dziduszko A; Ozbun MA
PLoS Pathog; 2012 Feb; 8(2):e1002519. PubMed ID: 22346752
[TBL] [Abstract][Full Text] [Related]
4. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.
Arii J; Goto H; Suenaga T; Oyama M; Kozuka-Hata H; Imai T; Minowa A; Akashi H; Arase H; Kawaoka Y; Kawaguchi Y
Nature; 2010 Oct; 467(7317):859-62. PubMed ID: 20944748
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
6. Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.
Schäfer G; Graham LM; Lang DM; Blumenthal MJ; Bergant Marušič M; Katz AA
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566373
[TBL] [Abstract][Full Text] [Related]
7. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
Johnson KM; Kines RC; Roberts JN; Lowy DR; Schiller JT; Day PM
J Virol; 2009 Mar; 83(5):2067-74. PubMed ID: 19073722
[TBL] [Abstract][Full Text] [Related]
8. The evolving field of human papillomavirus receptor research: a review of binding and entry.
Raff AB; Woodham AW; Raff LM; Skeate JG; Yan L; Da Silva DM; Schelhaas M; Kast WM
J Virol; 2013 Jun; 87(11):6062-72. PubMed ID: 23536685
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cell entry by human papillomaviruses: an overview.
Horvath CA; Boulet GA; Renoux VM; Delvenne PO; Bogers JP
Virol J; 2010 Jan; 7():11. PubMed ID: 20089191
[TBL] [Abstract][Full Text] [Related]
10. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry.
Murray MJ; Bonilla-Medrano NI; Lee QL; Oxenford SJ; Angell R; Depledge DP; Reeves MB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941787
[TBL] [Abstract][Full Text] [Related]
11. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection.
Carse S; Lang D; Katz AA; Schäfer G
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960740
[TBL] [Abstract][Full Text] [Related]
13. Folliculin Prevents Lysosomal Degradation of Human Papillomavirus To Support Infectious Cell Entry.
Ishii Y; Yamaji T; Sekizuka T; Homma Y; Mori S; Takeuchi T; Kukimoto I
J Virol; 2023 May; 97(5):e0005623. PubMed ID: 37167561
[TBL] [Abstract][Full Text] [Related]
14. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis.
Koganti R; Memon A; Shukla D
Semin Thromb Hemost; 2021 Apr; 47(3):283-294. PubMed ID: 33851373
[TBL] [Abstract][Full Text] [Related]
15. Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure.
Cerqueira C; Liu Y; Kühling L; Chai W; Hafezi W; van Kuppevelt TH; Kühn JE; Feizi T; Schelhaas M
Cell Microbiol; 2013 Nov; 15(11):1818-36. PubMed ID: 23601855
[TBL] [Abstract][Full Text] [Related]
16. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
17. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R
J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569
[TBL] [Abstract][Full Text] [Related]
18. Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry.
Choi J; DiMaio D
PLoS Pathog; 2023 Sep; 19(9):e1011648. PubMed ID: 37703297
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.
Siddiqa A; Massimi P; Pim D; Broniarczyk J; Banks L
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321327
[TBL] [Abstract][Full Text] [Related]
20. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry.
Arii J; Hirohata Y; Kato A; Kawaguchi Y
J Virol; 2015 Feb; 89(3):1879-88. PubMed ID: 25428876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
